Nano-X Imaging Ltd.
NASDAQ:NNOXMedical - Devices
-$0.03 today
- Market cap
- $50.94M
- Beta
- 1.17
- P/E (TTM)
- -1.5
- EPS (TTM)
- -$1.12
Volume 0.52M
Average 1.46M
NNOX Financing Cash Flow
Net cash exchanged with lenders and shareholders through borrowing, repayments, buybacks, and dividends.
Nano-X Imaging Ltd.NASDAQ: NNOX
Financing Cash Flow · Q4 FY2025 · quarter ended Dec 2025
Financing cash flow declines year over year
Q4 FY2025 financing cash flow of $16.54M fell 56.3% year over year, behind the -42.6% change in trailing-twelve-month financing cash flow. Sequentially, it rose 175.5% from the prior quarter. Over 3 fiscal years it compounded at +198.4% a year.
Context
- Financing cash flow amounted to 164.1% of revenue in FY2025, down 186.0 pp from a year earlier.
- Financing cash flow increased in 2 of the last 3 fiscal years.
What to watch
Whether quarterly growth recovers from -56.3% toward the trailing-twelve-month pace of -42.6%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Financing Cash Flow history
USD · from the cash flow
- Latest · FY2025
- 21.37M USD
- Year-over-year change
- -45.9%
- 4-year CAGR
- +30.4%
| Period | Period end | Financing Cash Flow | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 21.37M | -45.9% |
| FY2024 | 2024-12-31 | 39.5M | +45.0% |
| FY2023 | 2023-12-31 | 27.25M | +3289.6% |
| FY2022 | 2022-12-31 | 804K | -89.1% |
| FY2021 | 2021-12-31 | 7.38M | — |
Financing Cash Flow vs competitors
How NNOX compares with its peers on the latest reported figures
- NNOX's LTM Dec 2025 financing cash flow of $22.66M is the 6th largest of the 11 companies compared; the peer median is $313K.
- Its year-over-year change of -42.6% is the 6th highest of 11, against a peer median of -30.2%.
- Financing cash flow amounts to 174.0% of revenue for NNOX, versus a peer median of 46.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $442.16M | +4786.8% | +192.9% | 4611.1% | |
| LTM Mar 2026 | $231.07M | -258.1% | +348.5% | 76.4% | |
| LTM Mar 2026 | $164.7M | +23.8% | +468.8% | 26649.8% | |
| LTM Mar 2026 | $63.46M | +42.6% | +31.7% | 141.4% | |
| LTM Mar 2026 | $42.24M | +23.6% | +81.2% | 223.8% | |
| LTM Dec 2025 | $22.66M | -42.6% | +198.4% | 174.0% | |
| LTM Mar 2026 | $6.95M | -211.1% | — | 15.7% | |
| LTM Mar 2026 | $1.89M | -107.9% | +299.2% | 0.5% | |
| LTM Mar 2026 | $1.57M | +3042.0% | — | 1.1% | |
| LTM Mar 2026 | $348K | -99.4% | -8.7% | 0.3% | |
| LTM Mar 2026 | $278K | -84.0% | -39.0% | 0.9% | |
| Peer median (excluding NNOX) | $313K | -30.2% | +137.1% | 46.0% | |
Competitors are the stored peer set for NNOX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (61.8M) | (105.24M) | (60.78M) | (53.52M) | (75.02M) |
| Depreciation & Amortization | 2.29M | 11.51M | 11.81M | 11.73M | 11.7M |
| Deferred Income Tax | (116K) | (3.73M) | (377K) | (377K) | (1.98M) |
| Stock-Based Compensation | 18.81M | 18.62M | 6.84M | 7.26M | 4.19M |
| Change in Working Capital | 2.75M | (16.95M) | (7.48M) | (1.13M) | 2.77M |
| Accounts Receivables | (40K) | 74K | (507K) | (321K) | 107K |
| Inventory | 864K | 0 | 0 | (277K) | (325K) |
| Accounts Payables | 1.72M | 469K | (153K) | (1.32M) | 288K |
| Other Working Capital | 202K | (17.49M) | (6.82M) | 787K | 2.7M |
| Other Non-Cash Items | (2K) | 52.4M | 5.21M | (572K) | 17.54M |
| Operating Cash Flow | (38.07M) | (43.39M) | (44.78M) | (36.6M) | (40.79M) |
| Capital Expenditures | (23.16M) | (7.17M) | (3.3M) | (2.77M) | (4.21M) |
| Acquisitions (Net) | (2.86M) | 1.01M | 0 | 0 | 0 |
| Purchases of Investments | (90.3M) | (9.46M) | (373K) | (58.52M) | (15K) |
| Sales of Investments | 90.3M | 31.24M | 39.11M | 41.19M | 33.8M |
| Other Investing Activities | (90.3M) | (1.01M) | (373K) | 46K | (200K) |
| Investing Cash Flow | (116.32M) | 14.61M | 35.43M | (20.05M) | 29.37M |
| Debt Repayment | 3.8M | 0 | 0 | 0 | 0 |
| Common Stock Issued | 3.58M | 949K | 27.14M | 37.83M | 21.37M |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 3.58M | 804K | 113K | 1.67M | 0 |
| Financing Cash Flow | 7.38M | 804K | 27.25M | 39.5M | 21.37M |
| Effect of Forex Changes | (10K) | (268K) | (60K) | 72K | (101K) |
| Net Change in Cash | (147.01M) | (28.24M) | 17.85M | (17.07M) | 9.85M |
| Free Cash Flow | (61.23M) | (50.56M) | (48.08M) | (39.37M) | (45M) |
Nano-X Imaging Ltd.
NASDAQ:NNOX
Intrinsic Alpha fair value
Locked
Current Price
$0.73
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.